Towards an untargeted mass spectrometric approach for improved screening in equine antidoping.
- Publisher:
- John Wiley and Sons
- Publication Type:
- Journal Article
- Citation:
- Drug Testing and Analysis, 2021, 13, (5), pp. 1001-1007
- Issue Date:
- 2021-05
Open Access
Copyright Clearance Process
- Recently Added
- In Progress
- Open Access
This item is open access.
Full metadata record
Field | Value | Language |
---|---|---|
dc.contributor.author | Keen, B | |
dc.contributor.author | Cawley, A | |
dc.contributor.author | Fouracre, C | |
dc.contributor.author | Pyke, J | |
dc.contributor.author |
Fu, S https://orcid.org/0000-0002-6238-3612 |
|
dc.date.accessioned | 2022-01-19T02:47:27Z | |
dc.date.available | 2021-02-22 | |
dc.date.available | 2022-01-19T02:47:27Z | |
dc.date.issued | 2021-05 | |
dc.identifier.citation | Drug Testing and Analysis, 2021, 13, (5), pp. 1001-1007 | |
dc.identifier.issn | 1942-7603 | |
dc.identifier.issn | 1942-7611 | |
dc.identifier.uri | http://hdl.handle.net/10453/153346 | |
dc.description.abstract | The emergence of novel doping agents is a continuous issue for analysts who aim to maintain the integrity of horseracing together with the well-being and safety of the animals and riders involved. Untargeted mass spectrometric analysis presents a potential improvement for antidoping as it enables the detection of compounds being indirectly affected by an administered drug. In this study, liquid chromatography-high-resolution mass spectrometry was used to investigate a 12-horse administration study of the synthetic opioid, butorphanol. A mass spectrometric workflow capable of detecting metabolic differences for an extended period of time was successfully developed. This proof-of-concept study demonstrates the potential of untargeted workflows to provide a list of biomarkers of exposure and effect that are indicative of drug administration which may be implemented into routine testing for improved doping control. | |
dc.format | Print-Electronic | |
dc.language | eng | |
dc.publisher | John Wiley and Sons | |
dc.relation.ispartof | Drug Testing and Analysis | |
dc.relation.isbasedon | 10.1002/dta.3021 | |
dc.rights | info:eu-repo/semantics/openAccess | |
dc.subject | 0301 Analytical Chemistry, 0601 Biochemistry and Cell Biology, 1115 Pharmacology and Pharmaceutical Sciences | |
dc.subject.classification | Analytical Chemistry | |
dc.subject.mesh | Analgesics, Opioid | |
dc.subject.mesh | Animals | |
dc.subject.mesh | Butorphanol | |
dc.subject.mesh | Chromatography, High Pressure Liquid | |
dc.subject.mesh | Data Mining | |
dc.subject.mesh | Doping in Sports | |
dc.subject.mesh | Horses | |
dc.subject.mesh | Male | |
dc.subject.mesh | Mass Spectrometry | |
dc.subject.mesh | Proof of Concept Study | |
dc.subject.mesh | Reproducibility of Results | |
dc.subject.mesh | Substance Abuse Detection | |
dc.subject.mesh | Workflow | |
dc.subject.mesh | Analgesics, Opioid | |
dc.subject.mesh | Animals | |
dc.subject.mesh | Butorphanol | |
dc.subject.mesh | Chromatography, High Pressure Liquid | |
dc.subject.mesh | Data Mining | |
dc.subject.mesh | Doping in Sports | |
dc.subject.mesh | Horses | |
dc.subject.mesh | Male | |
dc.subject.mesh | Mass Spectrometry | |
dc.subject.mesh | Proof of Concept Study | |
dc.subject.mesh | Reproducibility of Results | |
dc.subject.mesh | Substance Abuse Detection | |
dc.subject.mesh | Workflow | |
dc.subject.mesh | Animals | |
dc.subject.mesh | Horses | |
dc.subject.mesh | Butorphanol | |
dc.subject.mesh | Analgesics, Opioid | |
dc.subject.mesh | Chromatography, High Pressure Liquid | |
dc.subject.mesh | Reproducibility of Results | |
dc.subject.mesh | Substance Abuse Detection | |
dc.subject.mesh | Doping in Sports | |
dc.subject.mesh | Male | |
dc.subject.mesh | Mass Spectrometry | |
dc.subject.mesh | Workflow | |
dc.subject.mesh | Data Mining | |
dc.subject.mesh | Proof of Concept Study | |
dc.title | Towards an untargeted mass spectrometric approach for improved screening in equine antidoping. | |
dc.type | Journal Article | |
utslib.citation.volume | 13 | |
utslib.location.activity | England | |
utslib.for | 0301 Analytical Chemistry | |
utslib.for | 0601 Biochemistry and Cell Biology | |
utslib.for | 1115 Pharmacology and Pharmaceutical Sciences | |
pubs.organisational-group | /University of Technology Sydney | |
pubs.organisational-group | /University of Technology Sydney/Faculty of Science | |
pubs.organisational-group | /University of Technology Sydney/Strength - CFS - Centre for Forensic Science | |
pubs.organisational-group | /University of Technology Sydney/Faculty of Science/School of Mathematical and Physical Sciences | |
pubs.organisational-group | /University of Technology Sydney/Strength - CCET - Centre for Clean Energy Technology | |
utslib.copyright.status | open_access | * |
pubs.consider-herdc | false | |
dc.date.updated | 2022-01-19T02:47:21Z | |
pubs.issue | 5 | |
pubs.publication-status | Published | |
pubs.volume | 13 | |
utslib.citation.issue | 5 |
Abstract:
The emergence of novel doping agents is a continuous issue for analysts who aim to maintain the integrity of horseracing together with the well-being and safety of the animals and riders involved. Untargeted mass spectrometric analysis presents a potential improvement for antidoping as it enables the detection of compounds being indirectly affected by an administered drug. In this study, liquid chromatography-high-resolution mass spectrometry was used to investigate a 12-horse administration study of the synthetic opioid, butorphanol. A mass spectrometric workflow capable of detecting metabolic differences for an extended period of time was successfully developed. This proof-of-concept study demonstrates the potential of untargeted workflows to provide a list of biomarkers of exposure and effect that are indicative of drug administration which may be implemented into routine testing for improved doping control.
Please use this identifier to cite or link to this item:
Download statistics for the last 12 months
Not enough data to produce graph